AbbVie Inc. (ABBV) vs Danaher Corporation (DHR)
ABBV leads on 10 of 15 compared metrics, though DHR is the cheaper stock.
A side-by-side comparison of AbbVie Inc. and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
ABBV
AbbVie Inc.
$253.38HealthcareDelayed quote: Jul 20, 2026, 4:02 PM EDT
DHR
Danaher Corporation
$201.11HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
Total return — ABBV vs DHR
growth of $100 · dividends reinvested · last 14yABBV +1148.1%DHR +504.9%ABBV compounded faster
ABBV DHR
ABBV vs DHR: by the numbers
- •ABBV is the larger company ($447.67B vs $142.34B market cap).
- •DHR trades at the lower earnings multiple (39.43 vs 124.79 P/E).
- •DHR converts more revenue to profit (14.89% vs 5.79% net margin).
- •ABBV grew revenue faster over the past five years (4.59% vs -0.02% CAGR).
- •ABBV pays the higher dividend yield (2.65% vs 0.67%).
Which is better, ABBV or DHR?
Metric tally: ABBV 10 · DHR 5It depends on what you're optimizing for:
ValueDHR(lower P/E)
GrowthABBV(faster 5Y revenue CAGR)
IncomeABBV(higher dividend yield)
QualityABBV(higher ROIC)
Metrics side by side
Valuation
| Metric | ABBV | DHR |
|---|---|---|
| P/E ratio | 124.79 | 39.43● |
| Forward P/E | — | 24.11 |
| P/S ratio | 7.19 | 5.85● |
| P/B ratio | 16.42 | 2.74● |
| PEG ratio | — | 98.56 |
| EV / EBITDA | 20.29● | 21.79 |
| FCF yield | 4.62%● | 3.65% |
Profitability
| Metric | ABBV | DHR |
|---|---|---|
| Gross margin | 70.68%● | 60.68% |
| Operating margin | 27.60%● | 20.95% |
| Net margin | 5.79% | 14.89%● |
| ROE | 13.23%● | 6.97% |
| ROIC | 12.97%● | 5.72% |
Dividends
| Metric | ABBV | DHR |
|---|---|---|
| Dividend yield | 2.65%● | 0.67% |
| Payout ratio | 284.39% | 26.82% |
Growth (annualized)
| Metric | ABBV | DHR |
|---|---|---|
| Revenue CAGR (5Y) | 4.59%● | -0.02% |
| EPS CAGR (5Y) | -2.79% | 0.40%● |
| FCF CAGR (5Y) | 3.24%● | -0.45% |
| Total return CAGR (5Y) | 21.31%● | -3.77% |
Frequently asked
- Which is better, ABBV or DHR?
- It depends on your goal. value: DHR (lower P/E); growth: ABBV (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, ABBV leads 10 to 5.
- Is ABBV or DHR cheaper?
- On trailing earnings, DHR is cheaper: ABBV trades at a 124.79 P/E and DHR at 39.43.
- Which has grown faster, ABBV or DHR?
- Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus DHR at -0.02%.
- Does ABBV or DHR pay a bigger dividend?
- ABBV yields 2.65% and DHR yields 0.67% based on trailing dividends and the latest price.
- Is ABBV or DHR more profitable?
- DHR runs the higher net margin — ABBV at 5.79% versus DHR at 14.89%.
- Which has been the better investment, ABBV or DHR?
- Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 19.69% versus DHR at 11.44%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioDanaher P/E ratioAbbVie dividend yieldDanaher dividend yieldAbbVie ROEDanaher ROEAbbVie operating marginDanaher operating marginAbbVie revenue growthDanaher revenue growthAbbVie free cash flowDanaher free cash flow
AbbVie & Danaher appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.